Rajkot, India

Murtuza Hadianawala

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Disc Medicine, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Murtuza Hadianawala. Retrieved from https://idiyas.com/inventor/murtuza-hadianawala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Murtuza Hadianawala: Innovator in Matriptase 2 Inhibition

Introduction

Murtuza Hadianawala is a notable inventor based in Rajkot, India. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit matriptase 2. His work is crucial for advancing therapeutic options in various medical applications.

Latest Patents

Murtuza holds a patent for "Matriptase 2 inhibitors and uses thereof." This invention provides compounds designed to inhibit matriptase 2, or its mutants, along with compositions and methods for their use. This patent represents a significant advancement in the understanding and treatment of conditions related to matriptase 2.

Career Highlights

Murtuza is currently associated with Disc Medicine, Inc., where he continues to innovate and contribute to the field. His work at the company focuses on developing new therapeutic strategies that leverage his expertise in matriptase inhibition.

Collaborations

Murtuza collaborates with esteemed colleagues such as Srikanth Venkatraman and Subhendu Mukherjee. These partnerships enhance the research and development efforts at Disc Medicine, Inc., fostering an environment of innovation and discovery.

Conclusion

Murtuza Hadianawala is a prominent figure in the field of biochemistry, with a focus on matriptase 2 inhibition. His patent and ongoing work at Disc Medicine, Inc. highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…